EBT
DGX icon

Enterprise Bank & Trust’s Quest Diagnostics DGX Stock Holding History

Enterprise Bank & Trust’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,819
Closed -$251K – 127
2023
Q4 		$251K Buy
+1,819
New +$239K 0.09% 110

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Enterprise Bank & Trust's DGX Position: Q1 2024 in Review

Enterprise Bank & Trust sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 1,819 shares — an estimated $251K sold.

Enterprise Bank & Trust first reported a position in DGX in Q4 2023 and held it in 1 quarter. The position peaked at $251K in Q4 2023. 818 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

  • Enterprise Bank & Trust reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
  • Enterprise Bank & Trust sold 1,819 Quest Diagnostics shares in Q1 2024, an estimated $251K.
  • Enterprise Bank & Trust first reported a position in Quest Diagnostics in Q4 2023 and held it in 1 quarter.
  • Enterprise Bank & Trust's Quest Diagnostics position peaked at $251K in Q4 2023.
  • 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Enterprise Bank & Trust's 13F filing for Q1 2024, filed 10 Apr 2024.